Ironwood Pharmaceuticals
IRWD
IRWD
227 hedge funds and large institutions have $1.12B invested in Ironwood Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 93 increasing their positions, 80 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
26% less capital invested
Capital invested by funds: $1.5B → $1.12B (-$383M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
59% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 51
Holders
227
Holding in Top 10
1
Calls
$73.6M
Puts
$186K
Top Buyers
1 | +$15.6M | |
2 | +$14.2M | |
3 | +$13.3M | |
4 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$11.1M |
5 |
Renaissance Technologies
New York
|
+$9.6M |
Top Sellers
1 | -$30.5M | |
2 | -$9.02M | |
3 | -$8.35M | |
4 |
UBS Group
Zurich,
Switzerland
|
-$7.75M |
5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$6.29M |